Synthetic Biology Market Size, Share, Trends, Industry Analysis Report: By Product (Oligonucleotide/Oligo Pools & Synthetic DNA, Enzymes, Cloning Technologies Kits, Xeno-Nucleic Acids, and Chassis Organism), Technology, Application, and Region (North Amer

The synthetic biology market size is expected to reach USD 78.16 billion by 2034, according to a new study by Polaris Market Research. The report “Synthetic Biology Market Size, Share, Trends, Industry Analysis Report: By Product (Oligonucleotide/Oligo Pools & Synthetic DNA, Enzymes, Cloning Technologies Kits, Xeno-Nucleic Acids, and Chassis Organism), Technology, Application, and Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) – Market Forecast, 2025–2034” gives a detailed insight into current market dynamics and provides analysis on future market growth.

Synthetic biology is an interdisciplinary field that applies engineering principles to biology, enabling the design and modification of biological systems for various applications, including healthcare, agriculture, and industrial biotechnology. The synthetic biology market growth is attributed to advancements in genome editing, increasing demand for sustainable bio-manufacturing, and the rising adoption of synthetic biology in drug discovery and personalized medicine. Opportunities in bio-based alternatives to petrochemicals, food innovation, and AI-driven biological engineering are further driving the market expansion. Key synthetic biology market trends include the integration of artificial intelligence for optimizing biological processes, regulatory developments to ensure biosecurity, and increasing investments and collaborations across industries. With expanding applications and technological progress, the market is poised for continued development across multiple sectors.

Synthetic Biology Market Report Highlights:

By product, the oligonucleotide/oligo pools & synthetic DNA segment holds the largest share of the synthetic biology market revenue in 2024 due to its critical role in gene synthesis, genome editing, and molecular diagnostics. The enzymes segment is witnessing rapid growth, driven by their increasing applications in DNA synthesis, PCR, and industrial biotechnology.

Based on technology, the genome editing technology segment dominated the synthetic biology market share, primarily due to the widespread adoption of CRISPR-based applications in drug development and agriculture. NGS technology is experiencing significant growth as sequencing costs decrease and demand for high-throughput genetic analysis increases.

Based on application, the healthcare segment holds the largest market share, with applications in gene therapy, synthetic vaccines, and precision medicine driving its dominance. The non-healthcare segment is growing rapidly, fueled by increasing demand for bio-based chemicals, engineered crops, and synthetic biology-driven environmental solutions.

North America holds the largest synthetic biology market share, supported by strong investments, research advancements, and a well-established biotechnology sector. Asia Pacific is the fastest-growing region, driven by expanding biotech infrastructure, increasing government funding, and rising adoption of synthetic biology in healthcare and industrial applications.

Several key players are actively contributing to advancements across various sectors. These include Amyris, Inc.; Bruker Cellular Analysis; BICO Group AB; Codexis, Inc.; Ginkgo Bioworks Holdings, Inc.; GenScript Biotech Corporation; Integrated DNA Technologies, Inc.; Insitro, Inc.; Novozymes A/S; Pivot Bio, Inc.; Twist Bioscience Corporation; Viridos, Inc.; and Zymergen Inc. (Acquired by Ginkgo Bioworks Holdings, Inc.

Polaris Market Research has segmented the synthetic biology market report on the basis of product, technology, application, and region:

By Product Outlook (Revenue – USD Billion, 2020–2034)

Oligonucleotide/Oligo Pools & Synthetic DNA

Enzymes

Cloning Technologies Kits

Xeno-Nucleic Acids

Chassis Organism

By Technology Outlook (Revenue – USD Billion, 2020–2034)

NGS Technology

PCR Technology

Genome Editing Technology

Bioprocessing Technology

Other Technologies

By Application Outlook (Revenue – USD Billion, 2020–2034)

Healthcare

Non-Healthcare

By Regional Outlook (Revenue – USD Billion, 2020–2034)

North America

US

Canada

Europe

Germany

France

UK

Italy

Spain

Netherlands

Russia

Rest of Europe

Asia Pacific

China

Japan

India

Malaysia

South Korea

Indonesia

Australia

Vietnam

Rest of Asia Pacific

Middle East & Africa

Saudi Arabia

UAE

Israel

South Africa

Rest of Middle East & Africa

Latin America

Mexico

Brazil

Argentina

Rest of Latin America